Quris-AI, an artificial intelligence (AI) company in the pharmaceutical space, extended its collaboration with Merck KGaA Darmstadt, Germany. This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches. Merck KGaA, Darmstadt, Germany will further leverage Quris-AI platform’s ability to identify liver toxicity risks in a selection of drug candidates. Subsequently, Merck...